Hans-Peter Deigner
Institute of Precision Medicine-Furtwangen University, Germany
Biography
Hans-Peter Deigner completed his PhD in Pharmaceutical Chemistry from Heidelberg University; Post-doctoral research at Harvard Medical School, Boston and then became Senior Lecturer at Heidelberg University. He has extensive experience in Biotechnology and Molecular Diagnostics including positions as Sr. Director Biomarker Research/CSO and share-holder of several biotech companies across Europe. From 2004-2006, he took up a chair in Biomedicinal Chemistry, School of Chemical Sciences and Pharmacy (CAP), University of East Anglia, Norwich, UK. Currently, he is Professor in the Faculty of Medical and Life Sciences (MLS), Furtwangen University and Co-director of Institute of Precision Medicine. He also holds an appointment as Visiting Scientist at Fraunhofer Institute IZI, Leipzig, Germany. He is author of more than 90 peer reviewed articles, 40 patents and patent applications. His research interests include “Precision diagnostics, biomarker and quantitative assay development, metabolomics and nanopore-sequencing”.
Abstract
Abstract : Metabolomics in precision diagnostics - asphyxia as an example